@ARTICLE{
author={McCrimmon Rory J|,Al Sifri Saud|,Emral Rifat|,Mohan Viswanathan|,Sauque-Reyna Leobardo|,Trescoli Carlos|,Lalic Nebojsa M|,Alvarez Agustina|,Demil Nacima|,Coudert Mathieu|,Shaunik Alka|,Bonnemaire Mireille|,Rosenstock Julio|},
year={2021},
title={Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial},
journal={DIABETES OBESITY & METABOLISM},
volume={23},
number={6},
pages={1221-1231},
document_type={Article},
}